Default Category
-
Cipla (Spanish version)
Deshpande, Rohit; Winig, LauraCase HBS-520S15MarketingThe head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line could become unsaleable (given that it is based on product patents protected in industrialized countries). Describes Cipla's role in forcing global pharmaceutical companies to lower th...Starting at €8.20